Mitamind 7.5mg Tablet
Prescription Required
Product introduction
Mitamind 7.5mg Tablet is used in the treatment of depression. This medicine works by increasing the level of chemical messengers (serotonin and noradrenaline) in the brain that help calm the brain and relax the nerves, thus treating your depression.
Mitamind 7.5mg Tablet is used to treat depression.
Mitamind 7.5mg Tablet is used to treat depression.
Uses of Mitamind Tablet
Benefits of Mitamind Tablet
In Treatment of Depression
Mitamind 7.5mg Tablet helps in maintaining the balance of certain chemicals in the brain that affect mood and behavior. This improves your mood, relieves anxiety, tension, helps you sleep better, and increases your energy levels. Mitamind 7.5mg Tablet prevents extreme mood changes and helps you feel less agitated. You may experience fewer episodes of depression and low mood.
It can take several weeks for Mitamind 7.5mg Tablet to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
It can take several weeks for Mitamind 7.5mg Tablet to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
Side effects of Mitamind Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mitamind
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mitamind Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mitamind 7.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Mitamind 7.5mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Mitamind 7.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Mitamind 7.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
The baby should be monitored for behavioral side effects and adequate growth.
The baby should be monitored for behavioral side effects and adequate growth.
Driving
UNSAFE
Mitamind 7.5mg Tablet may cause side effects which could affect your ability to drive.
Mitamind 7.5mg Tablet can affect your concentration or alertness. This may impair your driving ability.
Mitamind 7.5mg Tablet can affect your concentration or alertness. This may impair your driving ability.
Kidney
CAUTION
Mitamind 7.5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mitamind 7.5mg Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Mitamind 7.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Mitamind 7.5mg Tablet may be needed. Please consult your doctor.
What if you forget to take Mitamind Tablet?
If you miss a dose of Mitamind 7.5mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Mitamind 7.5mg Tablet
₹9.0/Tablet
Mirtaz 7.5 Tablet
Sun Pharmaceutical Industries Ltd
₹4.5/tablet
44% cheaper
Mirnite 7.5mg Tablet
Intas Pharmaceuticals Ltd
₹7.65/tablet
6% cheaper
Mirtee 7.5mg Tablet
Talent India
₹4.73/tablet
42% cheaper
Mirtakem 7.5mg Tablet
Alkem Laboratories Ltd
₹7.75/tablet
4% cheaper
Mirtadep 7.5mg Tablet
Torrent Pharmaceuticals Ltd
₹5.66/tablet
30% cheaper
Quick tips
- Mitamind 7.5mg Tablet starts to work more quickly than other antidepressants.
- Avoid driving or operating dangerous machinery as it may decrease alertness.
- Avoid consuming alcohol when taking the Mitamind 7.5mg Tablet, as it may cause excessive drowsiness and calmness.
- If your doctor asks you to stop Mitamind 7.5mg Tablet, you should reduce the dose slowly over 4 weeks. You should not discontinue it abruptly.
- Notify your doctor immediately if you develop a sore throat or fever or stomatitis during treatment with Mitamind 7.5mg Tablet.
Fact Box
Chemical Class
Piperazinoazepine Tetracyclic
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Noradrenergic and specific serotonergic antidepressants (NASSAs)
Patient concerns
FAQs
Is Mitamind 7.5mg Tablet addictive?
No, Mitamind 7.5mg Tablet is not addictive. Patient should follow the advice of the doctor regarding its use
Is Mitamind 7.5mg Tablet safe?
Mitamind 7.5mg Tablet is safe if used at prescribed dose and duration as advised by your doctor
Can I take Mitamind 7.5mg Tablet forever?
No, patient should take Mitamind 7.5mg Tablet for the given duration as advised by your doctor
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Mirtazapine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 441-45.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 925-26.
- Mirtazapine. Salt Lake City, Utah: Cephalon, Inc.; 2015. [Accessed 25 Mar 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Mirtazapine. [Updated 2019 Apr 1]. [Accessed 20 Feb. 2020] (online) Available from:
- Mirtazapine. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2006 [revised 15 Oct. 2018]. [Accessed 25 Mar 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Evangel Pharmaceuticals Private Limited
Address: 24, RAM NARAYAN MUKHERJEE ROAD SARSUNA KOLKATA Kolkata WB 700061 IN
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present